SCHEMBL19087556

SCHEMBL19087556

Cc1ccc(Nc2cc(C(C)(C)C)ccc2C)c(C)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAPGEF4 Q8WZA2 3/20 0.50
▸ LMNA P02545 2/20 0.42
▸ CSNK1D P48730 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ MEN1 O00255 4/20 0.40
▸ KMT2A Q03164 4/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ MAPK1 P28482 2/20 0.39
▸ HSD17B2 P37059 2/20 0.39
▸ TAS2R14 Q9NYV8 1/20 0.38
▸ RAB9A P51151 2/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ NFKB1 P19838 1/20 0.37
▸ NFKB2 Q00653 1/20 0.37
▸ RELA Q04206 1/20 0.37
▸ NLRP3 Q96P20 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ MAPK10 P53779 1/20 0.37
▸ TP53 P04637 1/20 0.36
▸ MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19087403 0.91 RAPGEF4 (0.53) RAPGEF4TSHRMEN1KMT2AHSD17B2
SCHEMBL23927543 0.85 CSNK1D (0.47) RAPGEF4LMNACSNK1DTSHRMEN1
SCHEMBL30719048 0.85 CSNK1D (0.47) RAPGEF4LMNACSNK1DTSHRMEN1
SCHEMBL24255017 0.84 TAS2R14 (0.41) RAPGEF4LMNACSNK1DTSHRMEN1
SCHEMBL19087611 0.82 TAS2R14 (0.50) LMNAMEN1KMT2ASMN1; SMN2MAPK1
SCHEMBL28318505 0.82 RAPGEF4 (0.42) RAPGEF4LMNACSNK1DTSHRMEN1
SCHEMBL17858235 0.81 RAPGEF4 (0.52) RAPGEF4CSNK1DTSHRMEN1KMT2A
SCHEMBL1334869 0.79 RAPGEF4 (0.74) RAPGEF4LMNAMEN1KMT2ASMN1; SMN2
SCHEMBL30320262 0.79 RAPGEF4 (0.74) RAPGEF4LMNAMEN1KMT2ASMN1; SMN2
SCHEMBL17858154 0.77 RAPGEF4 (0.50) RAPGEF4TSHRHSD17B2ALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110249030-B Organic electroluminescent device 材料科学有限公司 2023-04-18 — — CN disclosed
US-20190006592-A1 NOVEL ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME MATERIAL SCIENCE CO., LTD. (KR) 2019-01-03 — — US disclosed
US-20190006592-A1 NOVEL ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME MATERIAL SCIENCE CO., LTD. (KR) 2019-01-03 — — US disclosed
WO-2018128470-A1 ORGANIC ELECTROLUMINESCENT ELEMENT 머티어리얼사이언스 주식회사 2018-07-12 — — WO disclosed
WO-2017116169-A1 NOVEL ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME 머티어리얼사이언스 주식회사 2017-07-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190006592-A1 NOVEL ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME OCIAD1, OCIAD2, ORC3 RAPGEF4 2260/4885LMNA 2190/4885CSNK1D 3537/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback